SciSparc Ltd. (SPRC) AI Dilution Summary

Cash was $4,436,000 at 2026-06-30 against estimated monthly burn of $593,500, and the YA II PN, Ltd. standby equity purchase agreement is the stated funding facility. The only dated cash event after that date is a 2026-08-18 subsidiary placement of $1,900,000 net. That amount was SciSparc's own CAD$2.7M participation in NeuroThera, so it moves cash inside the group.